Diageo
DEO
84.73
-0.05
-0.06%
Diageo
US · DEO
#463 by market cap
Listed 1970
84.73
-0.05
-0.06%
Live - 5344 symbols - heartbeat 391s ago
· 2026-10-08 07:36
Pre-market
84.82
+0.11%
After-hours
84.73
0.00%
- Market cap
- 47.12B
- P/E (TTM)i
- 27.19
- P/Bi
- 4.33
- EPSi
- 3.12
- Div yieldi
- 3.92%
- 52W posi
- 43%
Reader sentiment
Are you bullish or bearish on DEO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.96, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.97% YoY
Margins
- Gross margin
- 59.47%
- Operating margin
- 16.07%
- Net margin
- 8.84%
Key ratios & quality
- Enterprise valuei
- 66.97B
- Altman Z-Scorei
- 1.96
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.31B | 14.47B | 17.62B | 20.52B | 20.56B | 20.27B | 20.25B | 19.64B |
| Gross profit | 10.14B | 8.74B | 10.65B | 12.59B | 12.27B | 12.20B | 12.17B | 11.68B |
| Selling & admin expenses | 2.59B | 2.27B | 2.99B | 3.62B | 3.66B | 3.69B | 3.66B | 3.18B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 5.12B | 4.29B | 5.16B | 5.90B | 5.55B | 6.00B | 4.34B | 3.16B |
| Pretax profit | 5.37B | 2.51B | 5.13B | 5.81B | 5.64B | 5.46B | 3.54B | 2.56B |
| Tax | 1.14B | 724.99M | 1.26B | 1.40B | 1.16B | 1.29B | 999.00M | 606.00M |
| Net profit | 4.23B | 1.79B | 3.87B | 4.41B | 4.48B | 4.17B | 2.54B | 1.96B |
| Basic EPS | 7 | 3 | 6 | 7 | 8 | 7 | 4 | 3 |
| Diluted EPS | 6.59 | 2.95 | 6.28 | 7.36 | 7.83 | 6.91 | 4.23 | 3.12 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- | -- | -- |
| Pretax profit | -- | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- | -- | -- |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 11.88B | 14.12B | 15.84B | 15.65B | 15.62B | 15.13B | 17.50B | 17.21B |
| Cash & ST investments | 1.34B | 4.18B | 3.87B | 3.07B | 2.06B | 1.41B | 2.65B | 1.78B |
| Inventory | 6.93B | 7.10B | 8.37B | 8.58B | 9.65B | 9.72B | 10.66B | 10.53B |
| Total assets | 39.66B | 41.00B | 44.22B | 44.18B | 44.88B | 45.47B | 49.32B | 46.85B |
| Total current liabilities | 8.87B | 8.00B | 9.88B | 10.22B | 9.59B | 9.87B | 10.71B | 10.73B |
| Short-term debt | 2.54B | 2.59B | 2.69B | 1.84B | 2.24B | 2.98B | 3.04B | 2.57B |
| Long-term debt | 13.43B | 18.20B | 17.81B | 17.54B | 18.65B | 18.62B | 20.82B | 19.06B |
| Total liabilities | 26,790,353,445.11 | 30,609,783,117.11 | 32,554,599,053.34 | 32,672,000,000.00 | 33,174,000,000.00 | 33,404,000,000.00 | 36,144,000,000.00 | 33,891,000,000.00 |
| Total equity | 12.87B | 10.39B | 11.67B | 11.51B | 11.71B | 12.07B | 13.18B | 12.95B |
| Retained earnings | 7.49B | 5.35B | 7.00B | 8.49B | 8.88B | 9.78B | 10.27B | 10.50B |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 16.79B | 15.13B | 16.76B | 17.50B | 18.89B | 17.21B |
| Cash & ST investments | 2.09B | 1.41B | 2.00B | 2.65B | 2.69B | 1.78B |
| Inventory | 9.84B | 9.72B | 9.70B | 10.66B | 10.56B | 10.53B |
| Total assets | 46.77B | 45.47B | 46.95B | 49.32B | 50.27B | 46.85B |
| Total current liabilities | 10.63B | 9.87B | 10.47B | 10.71B | 11.78B | 10.73B |
| Short-term debt | 2.00B | 2.98B | 2.50B | 3.04B | 3.30B | 2.57B |
| Long-term debt | 19.48B | 18.62B | 19.22B | 20.82B | 20.21B | 19.06B |
| Total liabilities | 35,041,000,000.00 | 33,404,000,000.00 | 34,541,000,000.00 | 36,144,000,000.00 | 36,578,000,000.00 | 33,891,000,000.00 |
| Total equity | 11.72B | 12.07B | 12.41B | 13.18B | 13.69B | 12.95B |
| Retained earnings | 8.95B | 9.78B | 10.39B | 10.27B | 10.91B | 10.50B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.12B | 2.86B | 5.06B | 5.21B | 3.64B | 4.11B | 4.30B | 4.39B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | 3.27B | 1.99B | 4.19B | 3.76B | 2.22B | 2.60B | 2.69B | 3.20B |
| Dividends paid | -2.06B | -2.03B | -2.28B | -2.30B | -2.07B | -2.24B | -2.30B | -1.85B |
| Stock buybacks / issuance | -3.45B | -1.51B | -83.04M | -2.96B | -1.64B | -966.00M | 15.00M | 1.00M |
| Ending cash balance | 913.71M | 3.88B | 3.65B | 2.68B | 1.77B | 1.11B | 2.18B | 1.49B |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 33.93 | 18.32 | 41.18 | 41.47 | 48.74 | 38.90 | 22.29 | 15.82 |
| ROA %i | 10.20 | 4.30 | 8.64 | 8.90 | 10.56 | 8.56 | 4.97 | 3.61 |
| ROIC %i | 16.07 | 7.19 | 13.37 | 14.22 | 17.44 | 14.47 | 8.82 | 6.84 |
| 5-year avg ROE %i | 29.71 | 27.09 | 30.25 | 33.69 | 36.92 | 37.92 | 38.71 | 33.64 |
| EBIT margin %i | 36.85 | 22.24 | 33.00 | 31.64 | 32.31 | 32.53 | 22.92 | 18.52 |
| FCF / sales %i | 20.03 | 13.78 | 23.78 | 18.37 | 10.78 | 12.80 | 13.26 | 16.27 |
| Current ratioi | 1.34 | 1.77 | 1.60 | 1.53 | 1.63 | 1.53 | 1.63 | 1.60 |
| Quick ratioi | 0.49 | 0.79 | 0.67 | 0.65 | 0.51 | 0.44 | 0.54 | 0.44 |
| Debt / assetsi | 40.53 | 51.80 | 47.23 | 43.87 | 47.58 | 48.61 | 49.47 | 47.38 |
| LT debt / equityi | 127.75 | 223.77 | 190.60 | 185.94 | 193.98 | 190.64 | 192.62 | 180.56 |
| Interest coveragei | 9.37 | 4.58 | 8.47 | 9.74 | 6.96 | 5.81 | 4.20 | 3.39 |
| Revenue CAGR (3Y) %i | 5.23 | -2.65 | 3.48 | 7.96 | 12.42 | 4.77 | -0.44 | -1.50 |
| Net income CAGR (3Y) %i | 10.16 | -20.59 | -2.33 | 2.24 | 36.85 | 1.68 | -18.07 | -26.89 |
| FCF CAGR (3Y) %i | 6.21 | -16.30 | 8.64 | 4.77 | 3.63 | -14.77 | -10.59 | 12.92 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 42.88 | 38.90 | 35.82 | 22.29 | 22.06 | 15.82 |
| ROA %i | 9.00 | 8.56 | 7.67 | 4.97 | 4.97 | 3.61 |
| ROIC %i | 15.75 | 14.47 | 13.62 | 8.82 | 9.02 | 6.84 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 30.67 | 32.53 | 31.06 | 22.92 | 23.44 | 18.52 |
| FCF / sales %i | 13.68 | 12.80 | 13.48 | 13.26 | 12.67 | 16.27 |
| Current ratioi | 1.58 | 1.53 | 1.60 | 1.63 | 1.60 | 1.60 |
| Quick ratioi | 0.63 | 0.44 | 0.62 | 0.54 | 0.60 | 0.44 |
| Debt / assetsi | 45.93 | 48.61 | 46.27 | 49.47 | 46.77 | 47.38 |
| LT debt / equityi | 198.92 | 190.64 | 186.93 | 192.62 | 174.20 | 180.56 |
| Interest coveragei | 5.84 | 5.81 | 5.59 | 4.20 | 4.27 | 3.39 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
Rest of world71.19%
United States37.71%
India16.36%
Great Britain16.08%
Quote time 2026-10-08 07:36:31 · For reference only, not investment advice and not tailored to your situation.